FDA Issues Warning Letters to Unlicensed E-cigarette Sellers and Retailers

Sep.14
FDA Issues Warning Letters to Unlicensed E-cigarette Sellers and Retailers
FDA issues 11 warning letters to companies for unauthorized e-cigarette products sales at trade shows, emphasizing crackdown on illegal behavior.

According to a report on the official website of the US Food and Drug Administration (FDA) on September 13th, the agency has issued 11 warning letters to multiple manufacturers and retailers for selling or distributing unauthorized e-cigarette products at industry trade shows.

FDA Issues Warning Letters to Unlicensed E-cigarette Sellers and Retailers


The FDA's Center for Tobacco Products (CTP) conducted an investigation after attending a trade show and found that six retailers and manufacturers were suspected of selling or distributing unauthorized e-cigarette products, violating regulations under the Federal Food, Drug, and Cosmetic Act. John Verbeten, Director of CTP's Office of Compliance and Enforcement, emphasized that the FDA will gather leads and conduct investigations through various channels, including trade shows, to crack down on illegal activities.


In addition, the FDA has issued warning letters to five online retailers accusing them of selling unauthorized e-cigarette products popular among teenagers, such as brands like Breeze, Mr. Fog, and Raz. These brands of e-cigarette products have high usage rates among teenagers and are favored for their wide variety of flavors.


Source: FDA official website.


Companies that have received a warning letter must respond within 15 business days, detailing the actions taken to address the violations and prevent future non-compliance. Companies that fail to address the issues in a timely manner may face further action by the FDA, including injunctions, seizures, or civil penalties.


The FDA's actions are part of its ongoing efforts to combat the unauthorized sale of e-cigarette products in the supply chain. Over the past year, the FDA has conducted multiple retailer inspections, exposing numerous cases of unauthorized e-cigarette sales, issuing over 690 warning letters, and imposing more than 140 civil penalties on retailers.


It is worth noting that the percentage of American teenagers using e-cigarettes decreased by nearly 25% between 2023 and 2024, dropping from 2.13 million to 1.63 million. The FDA has authorized 34 types of e-cigarette products and devices that are legally sold in the United States. The public can access further information about legally marketed tobacco products in the FDA's searchable tobacco product database. With increasing global regulations on e-cigarettes, governments around the world are taking unprecedented measures to combat illegal e-cigarette activities. From the seizure of over a thousand untaxed e-cigarettes by German customs, to the sales bans imposed by the Department of Trade and Industry in the Philippines on brands such as Relx, Flare, Team X, and Funky Monkey, these actions not only demonstrate the government's commitment to protecting public health and upholding tax regulations but also reflect the international community's collective efforts in combating illegal e-cigarette trade.


Notice

1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.

2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.

3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.

Copyright

This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.

This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.